Botulinum toxin type A (Nabota) is indicated for the temporary treatment of glabellar lines associated with cardboard lines. Botulinum toxin type A (Nabota) is indicated for the temporary improvement in the appearance of the upper respiratory tract (forehead lines, crow’s feet, and forehead lines) in adults. In people with chronic migraines, botulinum toxin type A (Nabota) is recommended for the prevention of headaches.
For the treatment of adult urinary incontinence brought on by neurogenic detrusor overactivities, such as spinal cord injury (SCI) or multiple sclerosis (MI), botulinum toxin type A (Nabota) is recommended.
Nabota Product info:
Product Name: Nabota100
Main Ingredients: Clostridium botulinum toxin type A (standard) -100 units (Nabota100)
Duration: 6 months
Packing: 1 vial
Storage: 2 ~ 8°C
INDICATION
•Temporarily lessening of ripple and lower abdomen activity-related moderate to severe glabellar lines in adult patients.
•Adult patients’ upper limb spasticity treatment.
•Temporary reduction in the severity of lateral angular lines that are related to ocular activity in adult patients.
•Treatment for adult patients with blepharospasm brought on by dystonia
Botulinum toxin type A (Nabota) offers a versatile range of applications, catering to various medical and aesthetic needs with remarkable efficacy. Its indications extend beyond cosmetic enhancements to encompass therapeutic interventions for conditions such as urinary incontinence, upper limb spasticity, and blepharospasm.
The temporary treatment of glabellar lines, upper respiratory tract lines, and forehead lines, among others, underscores its significance in addressing aesthetic concerns associated with aging. Additionally, its role in managing chronic migraines provides relief to individuals burdened by persistent headaches.
Furthermore, Nabota’s effectiveness in managing neurogenic detrusor overactivity-related urinary incontinence, particularly in patients with spinal cord injuries or multiple sclerosis, highlights its therapeutic potential in improving quality of life for those affected by such conditions.
With each vial containing 100 units of Clostridium botulinum toxin type A, Nabota ensures consistent potency for optimal results. Its duration of action, lasting up to six months, offers sustained benefits, enhancing patient satisfaction and minimizing the need for frequent interventions.
Nabota’s storage requirements, between 2°C to 8°C, ensure product stability and integrity, maintaining its efficacy until administration.
You’ll be pleasantly delighted to discover such natural effects at a price that is really reasonable.
